| 28.01.2025 14:56 | APTA | Issue of Equity in lieu of Director fees | RNS |
| 28.01.2025 07:00 | APTA | Half Year Trading Update | RNS |
| 13.01.2025 11:40 | APTA | Notification of dealings by a director/PDMR | RNS |
| 03.01.2025 12:02 | APTA | Aptamer signs development contract with biopharmaceutical firm | Alliance |
| 30.12.2024 07:00 | APTA | Holding(s) in Company | RNS |
| 19.12.2024 16:44 | APTA | Notification of dealings by a director/PDMR | RNS |
| 19.12.2024 07:00 | APTA | New Development Contract | RNS |
| 18.12.2024 10:53 | APTA | TR-1: Standard form notification of major holdings | RNS |
| 16.12.2024 11:28 | APTA | Notification of dealings by a director/PDMR | RNS |
| 10.12.2024 12:54 | APTA, VCP, HTWS | DIRECTOR DEALINGS: Helios Towers director buys GBP200,000 in shares | Alliance |
| 06.12.2024 07:00 | APTA | New Scientific Advisory Board Members | RNS |
| 05.12.2024 19:52 | SURE, CLC, EMVC | EARNINGS AND TRADING: Synectics deal wins; TruFin to beat expectations | Alliance |
| 05.12.2024 07:00 | APTA | Technical Update | RNS |
| 04.12.2024 07:00 | APTA | Investor Webinar | Reach |
| 29.11.2024 11:05 | APTA | Results of 2024 Annual General Meeting | RNS |
| 29.11.2024 07:00 | APTA | AGM Statement | RNS |
| 22.11.2024 11:35 | SLP, MSMN, EUZ | UK shareholder meetings calendar - next 7 days | Alliance |
| 07.11.2024 10:46 | FADL, APTA, DSW | AIM WINNERS & LOSERS: Fadel lowers forecasts on contract setbacks | Alliance |
| 07.11.2024 07:00 | APTA | Agreement extended with genetic medicines customer | RNS |
| 06.11.2024 07:00 | APTA | Commercial Trading Update | RNS |
| 05.11.2024 07:00 | APTA | Posting of Annual Report and Notice of AGM | RNS |
| 22.10.2024 07:00 | APTA | Full Year Results for the 12mths to 30 June 2024 | RNS |
| 17.10.2024 07:00 | APTA | Notice of Results and Investor Presentation | RNS |
| 16.09.2024 07:00 | APTA | Director Appointment | RNS |
| 03.09.2024 11:05 | ULVR, APTA | Aptamer Group extends Optimer development contract with Unilever | Alliance |
| 03.09.2024 07:00 | APTA | Aptamer extends contract with Unilever | RNS |
| 27.08.2024 07:00 | APTA | Block listing Interim Review | RNS |
| 20.08.2024 14:26 | APTA | Holding(s) in Company | RNS |
| 16.08.2024 13:04 | APTA | TR-1: Standard form notification of major holdings | RNS |
| 14.08.2024 11:34 | APTA | TR-1: Standard form notification of major holdings | RNS |
| 13.08.2024 12:57 | APTA | Result of General Meeting and Board Changes | RNS |
| 06.08.2024 14:33 | TEP, SKA, CML | UK shareholder meetings calendar - next 7 days | Alliance |
| 01.08.2024 16:33 | APTA | Supplementary Conditional Placing for £60,000 | RNS |
| 24.07.2024 18:11 | APTA | Posting of Circular and Notice of General Meeting | RNS |
| 24.07.2024 12:37 | APTA | Fundraise to Raise £2.83 million | RNS |
| 08.07.2024 10:55 | ULVR, APTA | Aptamer says annual revenue halves but hails progress with Unilever | Alliance |
| 08.07.2024 07:05 | APTA | Update on progress in Unilever partnership | RNS |
| 08.07.2024 07:00 | APTA | Trading Update | RNS |
| 03.07.2024 10:44 | ECR, APTA, PYC | AIM WINNERS & LOSERS: Aptamer rises on AstraZeneca contract | Alliance |
| 03.07.2024 09:57 | AZN, APTA | Aptamer shares jump as inks agreement with AstraZeneca | Alliance |
| 03.07.2024 07:00 | APTA | Agreement to explore Optimer vehicles for siRNA | RNS |
| 24.06.2024 11:48 | APTA | Aptamer shares rise as inks two new contracts worth GBP235,000 | Alliance |
| 24.06.2024 07:00 | APTA | New Contracts Announcement for Optimer Development | RNS |
| 14.06.2024 07:00 | APTA | Partnership with Microsaic Systems | RNS |
| 31.05.2024 16:06 | APTA | Holding(s) in Company | RNS |
| 28.05.2024 09:05 | APTA | Holding(s) in Company | RNS |
| 23.05.2024 14:56 | BMY, BMS, APTA | TRADING UPDATES: Bloomsbury books profit jump; Braemar profit slips | Alliance |
| 23.05.2024 07:00 | APTA | New contracts with top ten pharma partners | RNS |
| 22.05.2024 12:24 | APTA | Aptamer shares up on GBP465,000 cervical cancer contract with Timser | Alliance |
| 22.05.2024 07:00 | APTA | Aptamer and Timser Partnership | RNS |
| 13.05.2024 13:19 | ULVR, APTA | Aptamer says sales pipeline "strong" as reports strategic headway | Alliance |
| 13.05.2024 07:45 | APTA | Trading Update | RNS |
| 25.04.2024 15:45 | APTA | Holding(s) in Company | RNS |
| 24.04.2024 08:45 | APTA | Holding(s) in Company | RNS |
| 23.04.2024 14:03 | APTA | Holding(s) in Company - REPLACEMENT | RNS |
| 22.04.2024 20:03 | TPOU, MHN, CCL | EARNINGS AND TRADING: Zenova's Kitemark award; Carnival's eyes savings | Alliance |
| 22.04.2024 16:37 | APTA | Holding(s) in Company | RNS |
| 22.04.2024 07:00 | APTA | Top Pharma Company evaluates Optimer for medicine | RNS |
| 18.04.2024 11:54 | APTA | Aptamer inks new Optimer+ transplant rejection therapy partnership | Alliance |
| 18.04.2024 10:06 | APTA | TR-1: Notification of major holdings | RNS |
| 18.04.2024 07:00 | APTA | Aptamer and Kairos Biotech partner for Optimer+ | RNS |
| 08.04.2024 14:27 | ULVR, APTA | Aptamer submits patent application for Optimer binders | Alliance |
| 08.04.2024 07:00 | APTA | Patent submission for Optimer® binders | RNS |
| 28.03.2024 14:07 | APTA | Holding(s) in Company | RNS |
| 28.03.2024 12:29 | ARBB, APTA, GSC | EARNINGS AND TRADING: Arbuthnot ups payout as profit more than doubles | Alliance |
| 28.03.2024 07:00 | APTA | Interim Results | RNS |
| 22.03.2024 07:00 | APTA | Notice of Interim Results & Investor Presentation | RNS |
| 14.03.2024 07:00 | APTA | Investor Webinar | Reach |
| 11.03.2024 11:08 | APTA, ULVR | Aptamer shares jump on successful Unilever contract progression | Alliance |
| 11.03.2024 07:00 | APTA | Aptamer Progresses Partnership with Unilever | RNS |
| 29.02.2024 07:00 | APTA | Block Listing Interim Review | RNS |
| 27.02.2024 14:27 | APTA | Aptamer says new Optimer+ delivers improved results | Alliance |
| 27.02.2024 07:00 | APTA | R&D progress on new Optimer®+ platform | RNS |
| 22.02.2024 13:21 | APTA | Aptamer and Neuro-Bio begin Alzheimer's test development second phase | Alliance |
| 22.02.2024 07:00 | APTA | Second Phase of Alzheimer's test with Neuro-Bio | RNS |
